shRNA介导GSTP1基因沉默对激素非依赖性前列腺癌细胞株DU145的影响  

Effect of gene GSTP1 silencing via shRNA transfection on androgen independent prostate cancer cell line Du145

作　　者：金鹏[1] 谢晋良[1] 朱向荣[1] 周成[1] 丁翔[1] 杨罗艳[2] 

机构地区：[1]中南大学湘雅医院器官移植中心,长沙410008 [2]中南大学湘雅二医院泌尿外科,长沙410011

出　　处：《中南大学学报（医学版）》2012年第8期807-816,共10页Journal of Central South University ：Medical Science

摘　　要：目的:探讨谷胱甘肽巯基转移酶P1(glutathione S-transferase P1,GSTP1)基因沉默对雄激素非依赖性前列腺癌细胞株DU145增殖活性和对化学治疗药物敏感性的影响。方法:根据选取靶序列形成短发卡状RNA(short hairpinRNA,shRNA)的DNA模板设计3条表达载体(shRNA255,shRNA554,shRNA593),并克隆到质粒pGPU6/GFP/Neo。经酶切和测序鉴定,筛选转染率最高基因沉默效果最好的shRNA作RNA干扰。DU145细胞株分为空白质粒转染组和shRNA转染组。转染前后按化学治疗药物分为氟尿嘧啶(fluorouracil,FU)组及紫杉醇(paclitaxel,PA)组,并按作用浓度(FU:30,60,120,240μg/mL;PA:0.2,2,10,20μg/mL)分别分成4个亚组,并分别设有一个空白对照组。四甲基偶氮唑盐[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide,MTT]比色法检测转染后细胞增殖活性的变化,MTT及末端脱氧核苷酸转移酶介导脱氧尿苷三磷酸缺口末端标记法(terminal de-oxynucleotidyl transferase-mediated dUTP nick end labeling,TUNEL)检测转染前后不同浓度FU和PA对DU145细胞抑制增殖及诱导凋亡的效果。结果:3条表达载体(pGPU6/GFP/Neo-shRNA255,pGPU6/GFP/Neo-shRNA554,pGPU6/GFP/Neo-shRNA593)的转染率分别为(63.3±1.04)%,(76.2±0.68)%,(72.7±0.33)%,shRNA554转染率最高,三者之间比较差异有统计学意义(P<0.01)。转染后mRNA含量分别为128.31±2.50,43.24±4.30和85.62±6.30,GSTP1蛋白含量分别为163.92±12.40,65.38±9.30和114.25±16.70,shRNA554转染后GSTP1基因mRNA和蛋白含量均最低,三者比较差异有统计学意义(P<0.01)。MTT检测转染前FU不同浓度(30,60,120,240μg/mL)四个亚组作用后细胞存活率分别为(95.60±2.11)%,(90.20±0.86)%,(83.10±3.12)%和(74.60±1.32)%;转染后存活率为(91.30±1.43)%,(84.6±2.13)%,(73.2±1.52)%和(65.5±0.94)%。TUNEL检测转染前FU不同浓度(30,60,120,240μg/mL)四个亚组作用后细胞凋亡率分别为(5.50±0.88)%,(10.20±1.64)%,(15.20±2.39)%和(25.10±2.59)%;转染后凋亡率(10.80±0.62)%,Objective： To design short hairpin RNA（shRNA） interference sequence to silence glutathione S-transferase P1（GSTP1） gene of androgen independent prostate cancer cell line DU145,and to explore its effect on proliferation and sensitivity to chemotherapeutics. Methods： The target sequence was picked up to form the shRNA,and the 3 shRNA expression vectors were shRNA255,shRNA554 and shRNA593.The DNA template was cloned to plasmid pGPU6/GFP/Neo.The shRNA was identified by enzyme digesting and gene sequencing.The screening experiment was done to pick up the shRNA expression vector with the highest transfection ratio and best gene silencing results.DU145 cells were divided into a blank plasmid group and a shRNA transfected group.According to the chemotherapeutics the DU145 cells were divided into a fluorouracil（FU） group and a paclitaxel（PA） group,and the 2 groups were sub-divided into 4 subsets according to the chemotherapeutic concentrations（FU： 30,60,120,and 240 μg/mL;PA： 0.2,2,10,and 20 μg/mL）,meanwhile a blank control group was included respectively.3-（4,5-Dimethylthiazol-2-yl）-2,5-diphenyl tetrazolium bromide（MTT） assay was used to evaluate the proliferation after the transfection.MTT and terminal de-oxynucleotidyl transferase-mediated dUTP nick end labeling（TUNEL） assay were used to detect the inhibition effect of different concentrations of 5-FU or PA on the proliferation and induction of apoptosis of DU145. Results： The transfection ratio of the 3 shRNA expression vectors（shRNA255,shRNA554,and shRNA593） was（63.30±1.04）%,（76.20±0.68）%,and（72.70±0.33）%,and the transfection ratio of shRNA554 was the highest.there was significant difference among the above 3 shRNA expression vectors（P〈0.01）.After the transfection,the mRNA was 128.31±2.50,43.24±4.30 and 85.62±6.30,the GSTP1 protein was 163.92±12.40,65.38±9.30 and 114.25±16.70.After the transfection of shRNA554,the mRNA and protein of GSTP1 were the lowest level.there was significant difference

关 键 词：前列腺癌细胞株DU145 短发卡状RNA 谷胱甘肽S-转移酶P1 化学治疗敏感性 

分 类 号：R737.25[医药卫生—肿瘤]